Skip to main content

Table 6 Histological scoring means, standard deviations, and Wilcoxon/Kruskal-Wallis results

From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study

Coating group

Endothelial cell loss

Surface fibrin

Neointimal/medial

Medial smooth muscle cell loss

Medial

Adventitial

Score

Platelets score

Fibrin score

Inflammation score

Depth

Circumference

Injury score

Inflammation score

Fibrosis score

Uncoated (n = 4)

0.08 ± 0.17

0.58 ± 1.17

0.83 ± 1.67

2.50 ± 1.04

0.25 ± 0.50

0.58 ± 1.17

0.42 ± 0.42

0.92 ± 1.26

0.00 ± 0.00

HPC-1 (n = 4)

0.17 ± 0.33

0.50 ± 0.58

0.00 ± 0.00

1.75 ± 0.74

0.00 ± 0.00

0.00 ± 0.00

0.25 ± 0.32

0.25 ± 0.32

1.50 ± 1.82

HPC-2 (n = 4)

0.50 ± 0.64

0.58 ± 0.69

0.33 ± 0.67

2.25 ± 0.57

0.50 ± 0.43

0.83 ± 1.23

0.50 ± 0.43

0.42 ± 0.63

1.50 ± 1.91

HPC-3 (n = 4)

0.25 ± 0.50

0.83 ± 1.26

0.92 ± 1.83

1.58 ± 0.96

0.42 ± 0.32

1.33 ± 1.22

0.58 ± 0.17

1.17 ± 0.88

0.00 ± 0.00

p value

0.731

0.963

0.762

0.384

0.183

0.144

0.514

0.522

0.181